Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of BridgeBio Pharma Inc (NASDAQ: BBIO) closed at $27.49 in the last session, up 3.97% from day before closing price of $26.44. In other words, the price has increased by $3.97 from its previous closing price. On the day, 2.49 million shares were traded. BBIO stock price reached its highest trading level at $28.2 during the session, while it also had its lowest trading level at $26.25.
Ratios:
We take a closer look at BBIO’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.19 and its Current Ratio is at 3.19.
On September 04, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $46.Piper Sandler initiated its Overweight rating on September 04, 2024, with a $46 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 19 ’24 when Kumar Neil sold 27,389 shares for $22.41 per share. The transaction valued at 613,826 led to the insider holds 4,897,443 shares of the business.
STEPHENSON BRIAN C sold 4,156 shares of BBIO for $93,137 on Nov 19 ’24. The Secretary, Treasurer & CFO now owns 93,758 shares after completing the transaction at $22.41 per share. On Nov 19 ’24, another insider, BRIAN STEPHENSON, who serves as the Officer of the company, bought 4,156 shares for $22.35 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BBIO now has a Market Capitalization of 5195335168 and an Enterprise Value of 6670284800. For the stock, the TTM Price-to-Sale (P/S) ratio is 24.81. Its current Enterprise Value per Revenue stands at 30.631 whereas that against EBITDA is -13.081.
Stock Price History:
Over the past 52 weeks, BBIO has reached a high of $44.32, while it has fallen to a 52-week low of $21.62. The 50-Day Moving Average of the stock is 9.96%, while the 200-Day Moving Average is calculated to be 1.27%.
Shares Statistics:
According to the various share statistics, BBIO traded on average about 2.35M shares per day over the past 3-months and 3636390 shares per day over the past 10 days. A total of 175.08M shares are outstanding, with a floating share count of 147.54M. Insiders hold about 21.93% of the company’s shares, while institutions hold 76.36% stake in the company. Shares short for BBIO as of 1731628800 were 17187425 with a Short Ratio of 7.31, compared to 1728950400 on 17779813. Therefore, it implies a Short% of Shares Outstanding of 17187425 and a Short% of Float of 13.96.
